
Pyrroloquinoline Quinone (PQQ) stands apart from most dietary ingredients as a redox cofactor capable of thousands of catalytic cycles without structural degradation. This extraordinary stability is central to PQQ’s role in cellular energy metabolism. However, the same quinone structure that enables this redox behavior also makes PQQ highly sensitive to light, oxygen, and moisture — environmental factors that degrade active content during manufacturing. Liposomal encapsulation places PQQ (CAS 72909-34-3) inside phospholipid bilayer vesicles, creating a protective barrier that shields the quinone core while preserving molecular integrity. The result: PQQ powder engineered for real-world manufacturing — from production line to consumer. Available at 50% and 70% loading.
Pyrroloquinoline Quinone is an aromatic tricyclic ortho-quinone — a molecular architecture that enables it to accept and donate electrons through repeated oxidation-reduction cycles. While most cofactors degrade after a few catalytic events, PQQ’s structure supports thousands of cycles without losing function. This exceptional catalytic stability is what makes PQQ biologically significant: it participates in cellular redox networks involved in mitochondrial energy metabolism.
The same quinone structure that enables redox cycling is also PQQ’s manufacturing vulnerability. Quinones are electron-rich and reactive — they readily interact with light (photo-oxidation), dissolved oxygen (auto-oxidation), and ambient moisture. In practical production terms, unencapsulated PQQ can show visible color shifts from reddish-brown toward darker tones, accompanied by measurable active-content decline during routine blending, capsule filling, and warehouse storage.
(1) Light & Oxygen Shield. The phospholipid bilayer acts as a physical barrier between encapsulated PQQ and environmental light/oxygen — the primary drivers of quinone degradation. This shielding reduces photo-oxidative damage during blending and capsule filling.
(2) Controlled Rehydration. Upon contact with water, liposomal vesicles swell gradually rather than bursting instantly. This modulated release supports uniform blend distribution in wet-granulation and beverage premix manufacturing.
(3) QC-Verified Quality. EE% ≥ 80% (dialysis/HPLC) confirms genuine encapsulation — distinguishing liposomal PQQ from simple physical blends with phospholipids. DLS sizing verifies 80–300 nm vesicles per batch. These are not one-off claims — they are routine QC data on every CoA.

PQQ’s sensitivity to light is a production-floor reality — not a laboratory curiosity. Unencapsulated PQQ exposed to ambient light during blending shows visible color shifts and active-content drift. The phospholipid bilayer delays photo-oxidative degradation, helping maintain the active content your label declares from blending to finished product on shelf.
50% suits multi-ingredient mitochondrial blends and CoQ10 combinations. 70% enables compact high-potency capsules with fewer pills per serving. Both grades share identical QC: same EE% thresholds, same DLS particle size ranges, same microbial and heavy metal screening.
EE% ≥ 80% (dialysis/HPLC) distinguishes genuine liposomal PQQ from simple blends. DLS sizing confirms consistent nano-scale vesicles batch to batch. This analytical distinction — whether PQQ is merely mixed with phospholipids or genuinely enclosed — is documented on every shipment CoA.
Phospholipids from non-GMO plant sources (sunflower or soy). PQQ produced via controlled fermentation — a nature-identical compound, chemically indistinguishable from PQQ found in trace amounts in soil and dietary sources. No synthetic surfactants or organic solvent residues above pharmacopeia limits.
Full HPLC quantification confirms exact 50% or 70% PQQ loading for every production batch. CoA issued with shipment-specific results — not a certificate of typical values.
Encapsulation Efficiency ≥ 80% confirms genuine liposomal encapsulation — the analytical distinction between a liposomal product and a PQQ-phospholipid physical blend.
Dynamic Light Scattering verifies uniform 80–300 nm vesicle dimensions across production lots. Consistent particle size is essential for reproducible dissolution and content uniformity.
Heavy metals ≤ 10 ppm (as Pb), USP microbial screening. Third-party ISO 17025 accredited laboratory testing available upon request.
These statements use structure/function language to describe established nutritional roles of PQQ. Not evaluated by regulatory authorities. Not intended to diagnose, treat, cure, or prevent any disease.
PQQ functions as a quinone cofactor capable of thousands of oxidation-reduction cycles. This catalytic efficiency enables participation in cellular redox networks that support normal energy metabolism.
Mitochondria depend on redox-active molecules to maintain their electron transport chain. PQQ’s quinone structure allows interaction with mitochondrial components involved in cellular energy production.
Cells maintain sophisticated endogenous antioxidant systems. PQQ’s repeated redox cycling is believed to contribute to these networks — not by replacing cellular defenses, but by participating in their normal function.
PQQ is commonly formulated alongside CoQ10 / ubiquinol, B vitamins, and amino acids. The liposomal format protects all co-formulated actives from mutual oxidative interactions during blending and storage.
PQQ combined with CoQ10 and B vitamins. Liposomal encapsulation protects both quinone actives (PQQ, CoQ10) from mutual oxidative interactions during co-processing.
PQQ paired with NR or NMN. Liposomal format stabilizes both ingredients — PQQ against oxidation, NR against moisture — during co-blending and storage.
70% grade enables compact 20–40 mg PQQ capsules — fewer pills per serving. Premium positioning for single-active PQQ dietary supplement SKUs.
PQQ in pre-workout and energy formulations alongside creatine, amino acids, and electrolytes. Free-flowing liposomal powder ensures homogeneous dry-blend distribution.